Abstract PD7-08: Gene Expression Profiling of Breast Cancer Brain Metastasis shows enrichment for non-luminal subtypes with potential prognostic implications
Gaia Griguolo(University of North Carolina at Chapel Hill), Valentina Guarneri(Istituto Oncologico Veneto), Luc Bauchet(Hôpital Gui de Chauliac), Jack Jacob(Alaska Women's Cancer Care), Claudia Pinato(Istituto Oncologico Veneto), Giovanni Zarrilli(University of Padua), Susan Fineberg(Albert Einstein College of Medicine), Matteo Fassan(University of Padua), Amélie Darlix(Institut de Recherche en Cancérologie de Montpellier), Stefano Piccolo(University of Padua), Francesca Zanconato(University of Padua), William Jacot(Inserm), Valérie Rigau(Université de Montpellier), Maria Cristina Guarascio(University of Padua), Michele Bottosso(University of Padua), Maria Vittoria Dieci(Istituto Oncologico Veneto), Francesca Schiavi(Istituto Oncologico Veneto), Federica Miglietta(University of Padua)
Cited by 0
Related Papers
Trastuzumab Deruxtecan in Previously Treated HER2-Low Advanced Breast Cancer
|New England Journal of Medicine|2022|2.5k
PI3K/AKT/mTOR signaling transduction pathway and targeted therapies in cancer
|Molecular Cancer|2023|1.9k
The Hippo Transducer TAZ Confers Cancer Stem Cell-Related Traits on Breast Cancer Cells
|Cell|2011|1.4k
Genome-wide association between YAP/TAZ/TEAD and AP-1 at enhancers drives oncogenic growth
|Nature Cell Biology|2015|1.2k
YAP/TAZ upstream signals and downstream responses
|Nature Cell Biology|2018|1.1k